Recruitment and Advertisement Guidance for Researchers

• The advertisement(s) described in the protocol application.
• Uploaded final printed ad, flyer, or audio/videotape with the protocol submission.

• Clearly state that the advertisement is for participation in a research project.
• State the purpose of the research.
• Summarize the eligibility criteria.
• Provide the benefits to the participant, if applicable.
• Indicate the time and participation commitment.
• Indicate the location of the research.
• Provide the name, address/email, and department of the Principal Investigator (PI).
• Provide a contact person and phone number.
• Indicate that WVU IRB approval or acknowledgement is on file.
• Do not imply a certainty of a favorable outcome or other benefits beyond the information contained in the consent document and the protocol.
• Do not include exculpatory language.
• Do not emphasize compensation by using a larger, bold, or different color font.

Advertisements for Research Involving Drugs, Devices, or other Test Articles:

• Do not make claims either explicitly or implicitly that the drug, biologic, or device was safe or effective for the purposes under investigation.
• Do not make claims either explicitly or implicitly that the drug, biologic, or device was known to be equivalent or superior to any other drug, biologic, or device. 
• Use terms such as "investigational new treatment," "investigational new medication," or "investigational new drug."
• Do not promise "free medical treatment" when the intent is to indicate that participants will not be charged for their participation in the research.
• If a placebo is used, clearly state that some participants may receive a placebo.